PharmiWeb.com - Global Pharma News & Resources

General - Press Releases

Date Title Company
01-Jun-2023 Pro-ficiency Launches Pf Library to Expand Study Training Service Suite Newswire
01-Jun-2023 PTP Announces Significant Investment by 424 Capital Businesswire
01-Jun-2023 Masimo Board of Directors Sets the Record Straight on False and Misleading Claims Businesswire
01-Jun-2023 Seven and Eight Biopharmaceuticals Announces Exclusive Clinical License Agreement with Eikon Therapeutics to Develop and Commercialize TLR7/8 dual agonists Businesswire
01-Jun-2023 Revvity’s EUROIMMUN Spearheads Cutting-Edge Diagnostic Analysis with New Automated IIFT System Businesswire
01-Jun-2023 Edge Group Global LLC Acquires Italian Soccer Team Casale Businesswire
01-Jun-2023 Arcturus Therapeutics Receives U.S. FDA Fast Track Designation for ARCT-810, mRNA Therapeutic Candidate for Ornithine Transcarbamylase Deficiency Businesswire
01-Jun-2023 Vistagen Presents Fasedienol (PH94B) Safety and Exploratory Efficacy Data from Phase 3 Open-Label Social Anxiety Disorder Study at American Society for Clinical Psychopharmacology Annual Meeting Businesswire
01-Jun-2023 Eikon Therapeutics Builds Leading Clinical Development Organization with Appointment of Senior Team with Extensive Industry Expertise Businesswire
01-Jun-2023 Biomarker Analysis Publication Highlights Key Signals of Disability Worsening Associated With Neuromyelitis Optica Spectrum Disorder (NMOSD) Attacks, Illustrates Efficacy of UPLIZNA® (inebilizumab-cdon) Businesswire
01-Jun-2023 Massive Bio Launches Revolutionary ChatGPT-Powered Chatbot Platform at ASCO 2023 to Simplify and Expand Access to Oncology Clinical Trials Businesswire
01-Jun-2023 Equillium to Present at the Jefferies Global Healthcare & LD Micro Invitational Conferences Businesswire
01-Jun-2023 Clarametyx Announces Positive Early Phase 1 Safety Findings on CMTX-101, Immune-Enabling Antibody Therapy Businesswire
01-Jun-2023 Inspirna to Present at the Jefferies Healthcare Conference Businesswire
01-Jun-2023 Eikon Therapeutics Acquires Global Rights to Clinical-Stage Assets and Announces Emerging Drug Development Pipeline Businesswire
01-Jun-2023 Rallybio to Present at the Jefferies Healthcare Conference Businesswire
01-Jun-2023 OcuTerra Appoints Bill Steinkrauss as Chief Financial Officer Businesswire
01-Jun-2023 MEI Pharma Board of Directors Rejects Unsolicited Proposal Businesswire
01-Jun-2023 Bio-Rad to Present Company Overview at Jefferies Healthcare Conference Businesswire
01-Jun-2023 Aviceda Announces Dosing of First Patient With AVD-104, a Novel Glyco-Mimetic Nanoparticle for the Treatment of Geographic Atrophy from Macular Degeneration, in the Phase 2 SIGLEC Trial Businesswire